A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-10-11

AUTHORS

Tomoko Matsumoto, Keiji Nogami, Midori Shima

ABSTRACT

Patients with mild/moderate hemophilia (H)A, acquired HA (AHA) and lupus anticoagulants (LA), have prolonged aPTTs with low levels of factor (F)VIII activity, but the differentiation of these disorders is complex and time consuming. We established an approach to quickly differentiate these disorders using comprehensive coagulation tests. Patients’ plasmas with mild/moderate HA, AHA, LA without anti-phospholipid syndrome [LA-APS(−)], and LA with APS [LA-APS(+)] were examined using clot waveform analysis (CWA) and thrombin generation test (TGT). Activated protein C (APC) sensitivity was assessed by TGT. CWA revealed similarly prolonged clot times in all groups [NP/mild/moderate HA/AHA/LA-APS(−)/LA-APS(+); 33 ± 1/82 ± 12/116 ± 44/90 ± 29/96 ± 15 s] but significantly different decreased maximal coagulation velocity (3.1 ± 0.1/1.3 ± 0.3/0.9 ± 0.5/1.6 ± 0.3/2.2 ± 0.5). In TGT, AHA group demonstrated severely reduced peak-thrombin levels (362 ± 23/170 ± 27/49 ± 21/158 ± 75/158 ± 99 nM), whilst both LA groups markedly prolonged lag times (4.5 ± 0.3/5.0 ± 0.4/4.7 ± 0.8/12.5 ± 7.7/28.8 ± 11.8 min), suggesting that AHA could be readily identified, but the different LA sub-types failed to be classified. An APC sensitivity demonstrated that ‘normalized’ APC-induced levels of peak thrombin in LA-APS(+) were significantly lower relative to LA-APS(−) (normalized %inhibition; 5 ± 7/42 ± 39 %). Our studies confirmed that %inhibition by APC was significantly decreased in NP preincubated with purified IgGs from LA-APS(+) compared to LA-APS(−), facilitating differentiation between LA groups. A combined approach using CWA and TGT could be a useful means of differentiating coagulation disorders with prolonged aPTT. More... »

PAGES

174-183

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12185-016-2108-x

DOI

http://dx.doi.org/10.1007/s12185-016-2108-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047393459

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27730530


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Coagulation Disorders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Coagulation Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diagnosis, Differential", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Factor VIII", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemophilia A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lupus Coagulation Inhibitor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Partial Thromboplastin Time", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Course of Hemophilia Treatment and Pathology, Nara Medical University, Kashihara, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Pediatrics, Nara Medical University, 840 Shijo-cho, 634-8522, Kashihara, Nara, Japan", 
            "Course of Hemophilia Treatment and Pathology, Nara Medical University, Kashihara, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsumoto", 
        "givenName": "Tomoko", 
        "id": "sg:person.0742772162.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742772162.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Nara Medical University, 840 Shijo-cho, 634-8522, Kashihara, Nara, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Pediatrics, Nara Medical University, 840 Shijo-cho, 634-8522, Kashihara, Nara, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nogami", 
        "givenName": "Keiji", 
        "id": "sg:person.0603447532.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603447532.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Course of Hemophilia Treatment and Pathology, Nara Medical University, Kashihara, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Pediatrics, Nara Medical University, 840 Shijo-cho, 634-8522, Kashihara, Nara, Japan", 
            "Course of Hemophilia Treatment and Pathology, Nara Medical University, Kashihara, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shima", 
        "givenName": "Midori", 
        "id": "sg:person.0705772523.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705772523.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12185-009-0450-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009175483", 
          "https://doi.org/10.1007/s12185-009-0450-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-10-11", 
    "datePublishedReg": "2016-10-11", 
    "description": "Patients with mild/moderate hemophilia (H)A, acquired HA (AHA) and lupus anticoagulants (LA), have prolonged aPTTs with low levels of factor (F)VIII activity, but the differentiation of these disorders is complex and time consuming. We established an approach to quickly differentiate these disorders using comprehensive coagulation tests. Patients\u2019 plasmas with mild/moderate HA, AHA, LA without anti-phospholipid syndrome [LA-APS(\u2212)], and LA with APS [LA-APS(+)] were examined using clot waveform analysis (CWA) and thrombin generation test (TGT). Activated protein C (APC) sensitivity was assessed by TGT. CWA revealed similarly prolonged clot times in all groups [NP/mild/moderate HA/AHA/LA-APS(\u2212)/LA-APS(+); 33\u00a0\u00b1\u00a01/82\u00a0\u00b1\u00a012/116\u00a0\u00b1\u00a044/90\u00a0\u00b1\u00a029/96\u00a0\u00b1\u00a015\u00a0s] but significantly different decreased maximal coagulation velocity (3.1\u00a0\u00b1\u00a00.1/1.3\u00a0\u00b1\u00a00.3/0.9\u00a0\u00b1\u00a00.5/1.6\u00a0\u00b1\u00a00.3/2.2\u00a0\u00b1\u00a00.5). In TGT, AHA group demonstrated severely reduced peak-thrombin levels (362\u00a0\u00b1\u00a023/170\u00a0\u00b1\u00a027/49\u00a0\u00b1\u00a021/158\u00a0\u00b1\u00a075/158\u00a0\u00b1\u00a099\u00a0nM), whilst both LA groups markedly prolonged lag times (4.5\u00a0\u00b1\u00a00.3/5.0\u00a0\u00b1\u00a00.4/4.7\u00a0\u00b1\u00a00.8/12.5\u00a0\u00b1\u00a07.7/28.8\u00a0\u00b1\u00a011.8\u00a0min), suggesting that AHA could be readily identified, but the different LA sub-types failed to be classified. An APC sensitivity demonstrated that \u2018normalized\u2019 APC-induced levels of peak thrombin in LA-APS(+) were significantly lower relative to LA-APS(\u2212) (normalized %inhibition; 5\u00a0\u00b1\u00a07/42\u00a0\u00b1\u00a039\u00a0%). Our studies confirmed that %inhibition by APC was significantly decreased in NP preincubated with purified IgGs from LA-APS(+) compared to LA-APS(\u2212), facilitating differentiation between LA groups. A combined approach using CWA and TGT could be a useful means of differentiating coagulation disorders with prolonged aPTT.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12185-016-2108-x", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5868440", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6822193", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6835617", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1076985", 
        "issn": [
          "0925-5710", 
          "1865-3774"
        ], 
        "name": "International Journal of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "105"
      }
    ], 
    "keywords": [
      "clot waveform analysis", 
      "thrombin generation test", 
      "lupus anticoagulant", 
      "coagulation disorders", 
      "prolonged aPTT", 
      "LA group", 
      "global coagulation assays", 
      "anti-phospholipid syndrome", 
      "protein C sensitivity", 
      "peak thrombin levels", 
      "moderate haemophilia", 
      "peak thrombin", 
      "coagulation tests", 
      "clot time", 
      "coagulation assays", 
      "FVIII activity", 
      "moderate HA", 
      "APTT", 
      "low levels", 
      "coagulation velocity", 
      "AHA group", 
      "disorders", 
      "patients", 
      "generation test", 
      "APC", 
      "group", 
      "waveform analysis", 
      "AHA", 
      "combined approach", 
      "anticoagulants", 
      "levels", 
      "syndrome", 
      "hemophilia", 
      "C sensitivity", 
      "lag time", 
      "IgG", 
      "APC sensitivity", 
      "differentiation", 
      "useful means", 
      "activity", 
      "thrombin", 
      "inhibition", 
      "sensitivity", 
      "test", 
      "assays", 
      "time", 
      "factors", 
      "study", 
      "HA", 
      "APS", 
      "analysis", 
      "approach", 
      "means", 
      "velocity", 
      "NPs"
    ], 
    "name": "A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity", 
    "pagination": "174-183", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047393459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12185-016-2108-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27730530"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12185-016-2108-x", 
      "https://app.dimensions.ai/details/publication/pub.1047393459"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T21:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_711.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12185-016-2108-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12185-016-2108-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12185-016-2108-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12185-016-2108-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12185-016-2108-x'


 

This table displays all metadata directly associated to this object as RDF triples.

198 TRIPLES      21 PREDICATES      95 URIs      86 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12185-016-2108-x schema:about N0ee3bf64506e4081b2bf165de1cd9630
2 N1831f0f623904c19be34d26611cf2714
3 N1afd2ac9292940f8999700f8cdf1e3e8
4 N33e05f21bcff41c4a2225a2e95565f0d
5 N540db690defe400dac3ae0d9e4c707b2
6 N59d4f162a1544bb9ba727c3ef666149a
7 N62b11211734942638ae64909c669e336
8 N86fa8584b7244c2b8c69c30ed299473c
9 Nb9a806c1494a43759b2f9ff50f694fa4
10 Nc14cf12b75204b4b86bf5820f9b31db6
11 Ncf92219dd1c54e879212c4651f638b86
12 Nd2e9d669f71d44848ad6cf9ffb19f231
13 Ndda641d838c34eea8d1a72b3a376b86f
14 Nf3932fd7952f4fb7b2fbaf5dff19bc27
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N5632220904d04b57a6800fc0a0039ce1
18 schema:citation sg:pub.10.1007/s12185-009-0450-y
19 schema:datePublished 2016-10-11
20 schema:datePublishedReg 2016-10-11
21 schema:description Patients with mild/moderate hemophilia (H)A, acquired HA (AHA) and lupus anticoagulants (LA), have prolonged aPTTs with low levels of factor (F)VIII activity, but the differentiation of these disorders is complex and time consuming. We established an approach to quickly differentiate these disorders using comprehensive coagulation tests. Patients’ plasmas with mild/moderate HA, AHA, LA without anti-phospholipid syndrome [LA-APS(−)], and LA with APS [LA-APS(+)] were examined using clot waveform analysis (CWA) and thrombin generation test (TGT). Activated protein C (APC) sensitivity was assessed by TGT. CWA revealed similarly prolonged clot times in all groups [NP/mild/moderate HA/AHA/LA-APS(−)/LA-APS(+); 33 ± 1/82 ± 12/116 ± 44/90 ± 29/96 ± 15 s] but significantly different decreased maximal coagulation velocity (3.1 ± 0.1/1.3 ± 0.3/0.9 ± 0.5/1.6 ± 0.3/2.2 ± 0.5). In TGT, AHA group demonstrated severely reduced peak-thrombin levels (362 ± 23/170 ± 27/49 ± 21/158 ± 75/158 ± 99 nM), whilst both LA groups markedly prolonged lag times (4.5 ± 0.3/5.0 ± 0.4/4.7 ± 0.8/12.5 ± 7.7/28.8 ± 11.8 min), suggesting that AHA could be readily identified, but the different LA sub-types failed to be classified. An APC sensitivity demonstrated that ‘normalized’ APC-induced levels of peak thrombin in LA-APS(+) were significantly lower relative to LA-APS(−) (normalized %inhibition; 5 ± 7/42 ± 39 %). Our studies confirmed that %inhibition by APC was significantly decreased in NP preincubated with purified IgGs from LA-APS(+) compared to LA-APS(−), facilitating differentiation between LA groups. A combined approach using CWA and TGT could be a useful means of differentiating coagulation disorders with prolonged aPTT.
22 schema:genre article
23 schema:isAccessibleForFree false
24 schema:isPartOf N5bb48d69652c4086a2ddd3365be366e6
25 Nde151fcb00ba4aa0a974f3e9e13a854d
26 sg:journal.1076985
27 schema:keywords AHA
28 AHA group
29 APC
30 APC sensitivity
31 APS
32 APTT
33 C sensitivity
34 FVIII activity
35 HA
36 IgG
37 LA group
38 NPs
39 activity
40 analysis
41 anti-phospholipid syndrome
42 anticoagulants
43 approach
44 assays
45 clot time
46 clot waveform analysis
47 coagulation assays
48 coagulation disorders
49 coagulation tests
50 coagulation velocity
51 combined approach
52 differentiation
53 disorders
54 factors
55 generation test
56 global coagulation assays
57 group
58 hemophilia
59 inhibition
60 lag time
61 levels
62 low levels
63 lupus anticoagulant
64 means
65 moderate HA
66 moderate haemophilia
67 patients
68 peak thrombin
69 peak thrombin levels
70 prolonged aPTT
71 protein C sensitivity
72 sensitivity
73 study
74 syndrome
75 test
76 thrombin
77 thrombin generation test
78 time
79 useful means
80 velocity
81 waveform analysis
82 schema:name A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity
83 schema:pagination 174-183
84 schema:productId N2677fd9fcdbd4d25be8eb6aad6804121
85 N60e3453902b443a0b151711c44c73479
86 Naa98d5cf74cf40ab988690d0e1123c53
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047393459
88 https://doi.org/10.1007/s12185-016-2108-x
89 schema:sdDatePublished 2022-11-24T21:00
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher Nac4a3274c5d048b294dcc22d747b3cb1
92 schema:url https://doi.org/10.1007/s12185-016-2108-x
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N0ee3bf64506e4081b2bf165de1cd9630 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Protein C
98 rdf:type schema:DefinedTerm
99 N1831f0f623904c19be34d26611cf2714 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Hemophilia A
101 rdf:type schema:DefinedTerm
102 N1afd2ac9292940f8999700f8cdf1e3e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N2677fd9fcdbd4d25be8eb6aad6804121 schema:name doi
106 schema:value 10.1007/s12185-016-2108-x
107 rdf:type schema:PropertyValue
108 N33e05f21bcff41c4a2225a2e95565f0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Factor VIII
110 rdf:type schema:DefinedTerm
111 N49f2b2c4231944969cfcdd8b4a54ca72 rdf:first sg:person.0705772523.06
112 rdf:rest rdf:nil
113 N540db690defe400dac3ae0d9e4c707b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Blood Coagulation Tests
115 rdf:type schema:DefinedTerm
116 N5632220904d04b57a6800fc0a0039ce1 rdf:first sg:person.0742772162.09
117 rdf:rest Nb7f8cc3455e441d199c3d456dad307e2
118 N59d4f162a1544bb9ba727c3ef666149a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Male
120 rdf:type schema:DefinedTerm
121 N5bb48d69652c4086a2ddd3365be366e6 schema:volumeNumber 105
122 rdf:type schema:PublicationVolume
123 N60e3453902b443a0b151711c44c73479 schema:name dimensions_id
124 schema:value pub.1047393459
125 rdf:type schema:PropertyValue
126 N62b11211734942638ae64909c669e336 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Diagnosis, Differential
128 rdf:type schema:DefinedTerm
129 N86fa8584b7244c2b8c69c30ed299473c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Lupus Coagulation Inhibitor
131 rdf:type schema:DefinedTerm
132 Naa98d5cf74cf40ab988690d0e1123c53 schema:name pubmed_id
133 schema:value 27730530
134 rdf:type schema:PropertyValue
135 Nac4a3274c5d048b294dcc22d747b3cb1 schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 Nb7f8cc3455e441d199c3d456dad307e2 rdf:first sg:person.0603447532.27
138 rdf:rest N49f2b2c4231944969cfcdd8b4a54ca72
139 Nb9a806c1494a43759b2f9ff50f694fa4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Thrombin
141 rdf:type schema:DefinedTerm
142 Nc14cf12b75204b4b86bf5820f9b31db6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Female
144 rdf:type schema:DefinedTerm
145 Ncf92219dd1c54e879212c4651f638b86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Partial Thromboplastin Time
147 rdf:type schema:DefinedTerm
148 Nd2e9d669f71d44848ad6cf9ffb19f231 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Blood Coagulation Disorders
150 rdf:type schema:DefinedTerm
151 Ndda641d838c34eea8d1a72b3a376b86f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Adult
153 rdf:type schema:DefinedTerm
154 Nde151fcb00ba4aa0a974f3e9e13a854d schema:issueNumber 2
155 rdf:type schema:PublicationIssue
156 Nf3932fd7952f4fb7b2fbaf5dff19bc27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Middle Aged
158 rdf:type schema:DefinedTerm
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
163 schema:name Clinical Sciences
164 rdf:type schema:DefinedTerm
165 sg:grant.5868440 http://pending.schema.org/fundedItem sg:pub.10.1007/s12185-016-2108-x
166 rdf:type schema:MonetaryGrant
167 sg:grant.6822193 http://pending.schema.org/fundedItem sg:pub.10.1007/s12185-016-2108-x
168 rdf:type schema:MonetaryGrant
169 sg:grant.6835617 http://pending.schema.org/fundedItem sg:pub.10.1007/s12185-016-2108-x
170 rdf:type schema:MonetaryGrant
171 sg:journal.1076985 schema:issn 0925-5710
172 1865-3774
173 schema:name International Journal of Hematology
174 schema:publisher Springer Nature
175 rdf:type schema:Periodical
176 sg:person.0603447532.27 schema:affiliation grid-institutes:grid.410814.8
177 schema:familyName Nogami
178 schema:givenName Keiji
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603447532.27
180 rdf:type schema:Person
181 sg:person.0705772523.06 schema:affiliation grid-institutes:grid.410814.8
182 schema:familyName Shima
183 schema:givenName Midori
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705772523.06
185 rdf:type schema:Person
186 sg:person.0742772162.09 schema:affiliation grid-institutes:grid.410814.8
187 schema:familyName Matsumoto
188 schema:givenName Tomoko
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742772162.09
190 rdf:type schema:Person
191 sg:pub.10.1007/s12185-009-0450-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1009175483
192 https://doi.org/10.1007/s12185-009-0450-y
193 rdf:type schema:CreativeWork
194 grid-institutes:grid.410814.8 schema:alternateName Course of Hemophilia Treatment and Pathology, Nara Medical University, Kashihara, Japan
195 Department of Pediatrics, Nara Medical University, 840 Shijo-cho, 634-8522, Kashihara, Nara, Japan
196 schema:name Course of Hemophilia Treatment and Pathology, Nara Medical University, Kashihara, Japan
197 Department of Pediatrics, Nara Medical University, 840 Shijo-cho, 634-8522, Kashihara, Nara, Japan
198 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...